Results 111 to 120 of about 1,335,871 (234)

Pembrolizumab for the treatment of non-small-cell lung cancer.

New England Journal of Medicine, 2015
E. Garon, N. Rizvi, R. Hui, N. Leighl, A. Balmanoukian, J. Eder, A. Patnaik, C. Aggarwal, M. Gubens, L. Horn, E. Carcereny, M. Ahn, E. Felip, Jong-Seok Lee, M. Hellmann, O. Hamid, J. Goldman, J. Soria, M. Dolled-Filhart, Ruth Z. Rutledge, Jin Zhang, J. Lunceford, Reshma A. Rangwala, G. Lubiniecki, C. Roach, K. Emancipator, L. Gandhi   +26 more
semanticscholar   +1 more source

An Analysis of G3BP2 in Non-Small Cell Lung Cancer. [PDF]

Cancers (Basel)
Bandi LSS, Timon L, O'Toole E, O'Connor D, Andersen K, Mohamed BM, Nicholson S, Fitzmaurice GJ, Ryan R, Young V, Cuffe S, Finn SP, Gray SG.   +12 more
europepmc   +1 more source

Can evolutionary therapy be applied in non-small cell lung cancer? [PDF]

Sci Rep
Jansén-Storbacka LR, Honasoge KS, Molnárová E, Soboleva A, Agema BC, Paats MS, Moes DJAR, Veerman GDM, Barbaro ABT, Dobbe R, Grossmann I, Azimi S, Mathijssen RHJ, Dingemans AC, Staňková K.   +14 more
europepmc   +1 more source

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

New England Journal of Medicine, 2006
A. Sandler, R. Gray, M. Perry, J. Brahmer, J. Schiller, A. Dowlati, R. Lilenbaum, David H. Johnson   +7 more
semanticscholar   +1 more source

Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer

Clinical and Translational Medicine
Haoran Li, Zheng Liu, Shaoyi Chen, Jingsheng Cai, Peiyu Wang, Kezhong Chen, Mantang Qiu   +6 more
doaj   +1 more source

Erlotinib in previously treated non-small-cell lung cancer.

New England Journal of Medicine, 2005
F. Shepherd, J. Rodrigues Pereira, T. Ciuleanu, E. Tan, V. Hirsh, S. Thongprasert, D. Campos, Savitree Maoleekoonpiroj, M. Smylie, R. Martins, M. van Kooten, M. Dediu, B. Findlay, D. Tu, D. Johnston, A. Bezjak, G. Clark, P. Santabarbara, L. Seymour   +18 more
semanticscholar   +1 more source

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Science, 2015
N. Rizvi, M. Hellmann, A. Snyder, P. Kvistborg, V. Makarov, J. Havel, William Lee, Jianda Yuan, P. Wong, Teresa Ho, Martin L. Miller, N. Rekhtman, A. Moreira, Fawzia Ibrahim, Cameron Bruggeman, Billel Gasmi, R. Zappasodi, Y. Maeda, C. Sander, E. Garon, T. Merghoub, J. Wolchok, T. Schumacher, T. Chan   +23 more
semanticscholar   +1 more source

Bronchoscopic ablation for non-small cell lung cancer. [PDF]

J Thorac Dis
Rangamuwa K, Steinfort D.
europepmc   +1 more source

Ivonescimab: promise or reality for advanced non-small cell lung cancer? [PDF]

Transl Lung Cancer Res
Olivares-Hernández A, Santa-Catalina PG, Fonseca-Sánchez E, Del Barco-Morillo E.   +3 more
europepmc   +1 more source

Early palliative care for patients with metastatic non-small-cell lung cancer.

New England Journal of Medicine, 2010
J. Temel, J. Greer, A. Muzikansky, E. Gallagher, S. Admane, V. Jackson, C. Dahlin, C. Blinderman, J. Jacobsen, W. Pirl, J. Billings, T. Lynch   +11 more
semanticscholar   +1 more source